Spring til hovednavigation
Spring til søgning
Spring til hovedindhold
Københavns Universitets forskningsportal Forside
Hjælp og OSS
Dansk
English
Forside
Profiler
Publikation
Forskningsenheder
Presse/medier
Aktiviteter
Priser
???studenttheses???
Forskningsdatasæt
Søg efter ekspertise, navn eller tilknytning
Carbenoxolone as a novel therapy for attenuation of cancer-induced bone pain
Sarah Falk
Neuronal Signalling
8
Citationer (Scopus)
Oversigt
Fingeraftryk
Fingeraftryk
Dyk ned i forskningsemnerne om 'Carbenoxolone as a novel therapy for attenuation of cancer-induced bone pain'. Sammen danner de et unikt fingeraftryk.
Sorter
Vægt
Alfabetisk
Keyphrases
Carbenoxolone
100%
Bone Cancer Pain
100%
Attenuation
100%
Novel Therapies
100%
Connexin
50%
Weight-bearing
33%
Beta-blockers
33%
Limb Use
33%
Bone Degradation
33%
Current Treatment
16%
Patients with Cancer
16%
Systemic Administration
16%
In Cancer
16%
Intrathecal Administration
16%
Mouse Tumor Model
16%
Minor Effect
16%
Disease Stage
16%
Major Complications
16%
Pharmacological Approaches
16%
Quality of Life
16%
Multiple Levels
16%
Connexin 43 (Cx43)
16%
Ongoing Pain
16%
Humane Endpoints
16%
Analgesic Potential
16%
Pain States
16%
Disease Progression
16%
Late-onset
16%
Cell-cell Communication
16%
Socioeconomic
16%
Cancer Pain
16%
Sham
16%
Analgesic Treatment
16%
Movement-evoked Pain
16%
Novel Analgesics
16%
Medicine and Dentistry
Carbenoxolone
100%
Malignant Neoplasm
100%
Bone Pain
100%
Gap Junction Protein
50%
Bone Defect
33%
Limb
33%
Weight Bearing
33%
Intrathecal Drug Administration
16%
Quality of Life
16%
Cell Communication
16%
Cancer Pain
16%
Systemic Administration
16%
Disease Exacerbation
16%
Mouse Model of Cancer
16%
Pharmacology, Toxicology and Pharmaceutical Science
Bone Pain
100%
Carbenoxolone
100%
Malignant Neoplasm
100%
Gap Junction Protein
50%
Analgesic Agent
33%
Bone Defect
33%
Cancer Pain
16%
Systemic Administration
16%
Mouse Model
16%
Disease Exacerbation
16%
Intrathecal
16%
Neuroscience
Carbenoxolone
100%
Gap Junction Protein
50%
Cell Communication
16%
Intrathecal
16%